Valuation: Integrum AB

Market Cap 209M 22M 19.05M 17.77M 16.31M 30.84M 2.1B 31.24M 82.04M 1.05B 82.63M 80.84M 3.49B P/E 2024
260x
P/E 2025 -8.99x
Enterprise Value 174M 18.35M 15.88M 14.81M 13.6M 25.72M 1.75B 26.05M 68.4M 872M 68.9M 67.4M 2.91B EV / Sales 2024
9.45x
EV / Sales 2025 2.63x
Free-Float
62.32%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 48 2025-05-04
Chief Executive Officer 66 2022-05-18
Director of Finance/CFO - 2025-09-14
Director TitleAgeSince
Chairman 66 -
Director/Board Member 65 2024-12-31
Director/Board Member 74 2024-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 24.55M
-1.93%+3.91%+0.75%-28.35% 19.68B
+0.73%+4.07%-1.03%-5.86% 16.15B
-1.85%+7.46%-61.60%-49.79% 5.51B
-1.58%+1.26% - - 4.13B
-1.05%+0.53%-12.38%-10.16% 1.85B
+0.38%+1.98%+42.30%+3.30% 1.74B
-0.95%+8.03%-44.77%-61.99% 1.2B
+1.85%+0.92%+81.37%+149.68% 917M
+1.50%-.--%+15.39%+205.50% 422M
Average -0.29%+2.64%+2.50%+25.29% 5.73B
Weighted average by Cap. -0.83%+3.80%-5.54%-16.65%

Financials

2024 2025
Net sales 110M 11.62M 10.07M 9.39M 8.62M 16.29M 1.11B 16.51M 43.34M 553M 43.66M 42.71M 1.84B 97.52M 10.26M 8.89M 8.29M 7.61M 14.39M 979M 14.57M 38.26M 488M 38.54M 37.71M 1.63B
Net income 4.03M 424K 367K 343K 315K 595K 40.49M 603K 1.58M 20.18M 1.59M 1.56M 67.3M -30.82M -3.24M -2.81M -2.62M -2.4M -4.55M -309M -4.6M -12.09M -154M -12.18M -11.92M -514M
Net Debt -10.48M -1.1M -955K -890K -817K -1.55M -105M -1.57M -4.11M -52.42M -4.14M -4.05M -175M -34.75M -3.66M -3.17M -2.95M -2.71M -5.13M -349M -5.19M -13.64M -174M -13.74M -13.44M -580M
Logo Integrum AB
Integrum AB is a Sweden-based company within healthcare sector. It provides systems for bone-anchored prostheses for individuals with amputations. The Company’s solutions comprise OPRA Implant System, neural prosthetics, phantom limb pain treatment and prosthetic components. The OPRA implant system is based on osseointegration, enabling the direct connection of an artificial limb to the skeleton. The neural prosthetics technology implies ability to directly connect bionic prostheses to the patient’s bone, nerves, and muscles. A method for limb pain treatment implies motor execution of the phantom limb as a treatment, which is aided by machine learning, augmented and virtual reality. The Company provides a variety of prosthetic components required to connect the OPRA Implant System to external prostheses.
Employees
-

Quarterly revenue - Rate of surprise